10 studies found for:    19717846 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of Ticagrelor
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Ticagrelor
2 Not yet recruiting Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
Conditions: Acute Coronary Syndrome;   Platelet Reactivity on Novel P2Y12 Inhibitors With and Without Aspirin
Intervention: Drug: Aspirin
3 Recruiting CARDIOBASE Bern PCI Registry
Condition: Myocardial Ischemia
Intervention: Procedure: Percutaneous coronary intervention
4 Not yet recruiting Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Condition: Myocardial Injury
Interventions: Drug: ticagrelor;   Drug: aspirin
5 Completed
Has Results
A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
6 Unknown  Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
Condition: Non-ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: Tirofiban;   Drug: Ticagrelor
7 Not yet recruiting Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Conditions: Cardiovascular Disease;   Interventional Cardiology
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
8 Not yet recruiting Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Cilostazol
9 Recruiting Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
Condition: Coronary Heart Disease
Interventions: Drug: Ticagrelor;   Drug: Prasugrel
10 Recruiting DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Placebo

Indicates status has not been verified in more than two years